Northern Trust Corp Acquires 202,509 Shares of RELX PLC $RELX

Key Points

• Northern Trust Corp increased its stake in Relx Plc by 9.2%, owning approximately 2.39 million shares worth $120.69 million as of the latest reporting period.
• Relx recently announced a semi-annual dividend of $0.2634 per share, which is set to be paid on September 16th, representing a yield of 170.0%.
• Wall Street analysts have upgraded Relx’s rating from "hold" to "buy", with the company currently holding an average rating of "Buy" from several analysts.

Northern Trust Corp lifted its holdings in shares of RELX PLC (NYSE:RELX - Free Report) by 9.2% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,394,097 shares of the technology company's stock after buying an additional 202,509 shares during the quarter. Northern Trust Corp owned about 0.13% of RELX worth $120,686,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also bought and sold shares of the company. Brooklyn Investment Group lifted its stake in RELX by 632.5% in the 1st quarter. Brooklyn Investment Group now owns 4,124 shares of the technology company's stock worth $208,000 after purchasing an additional 3,561 shares in the last quarter. Summit Securities Group LLC purchased a new stake in RELX in the 1st quarter worth approximately $194,000. Northwest & Ethical Investments L.P. lifted its stake in RELX by 5.3% in the 1st quarter. Northwest & Ethical Investments L.P. now owns 221,725 shares of the technology company's stock worth $11,177,000 after purchasing an additional 11,125 shares in the last quarter. Cresset Asset Management LLC lifted its stake in RELX by 10.7% in the 1st quarter. Cresset Asset Management LLC now owns 21,176 shares of the technology company's stock worth $1,067,000 after purchasing an additional 2,053 shares in the last quarter. Finally, American Century Companies Inc. lifted its stake in RELX by 4.0% in the 1st quarter. American Century Companies Inc. now owns 421,270 shares of the technology company's stock worth $21,236,000 after purchasing an additional 16,170 shares in the last quarter. 15.02% of the stock is currently owned by hedge funds and other institutional investors.

RELX Trading Down 0.7%

Shares of RELX stock traded down $0.32 on Friday, hitting $46.64. 1,853,527 shares of the company's stock traded hands, compared to its average volume of 1,586,397. The company has a debt-to-equity ratio of 2.55, a quick ratio of 0.42 and a current ratio of 0.47. RELX PLC has a one year low of $44.19 and a one year high of $56.33. The company's fifty day simple moving average is $51.18 and its 200 day simple moving average is $51.38. The stock has a market capitalization of $85.56 billion, a price-to-earnings ratio of 25.08, a P/E/G ratio of 3.06 and a beta of 0.88.

RELX Cuts Dividend

The firm also recently announced a semi-annual dividend, which will be paid on Tuesday, September 16th. Investors of record on Friday, August 8th will be issued a dividend of $0.2634 per share. The ex-dividend date of this dividend is Friday, August 8th. This represents a dividend yield of 170.0%. RELX's dividend payout ratio (DPR) is currently 28.49%.

Wall Street Analyst Weigh In

Separately, Wall Street Zen upgraded shares of RELX from a "hold" rating to a "buy" rating in a research note on Saturday, July 26th. One research analyst has rated the stock with a Strong Buy rating and four have assigned a Buy rating to the company. According to data from MarketBeat.com, the company has an average rating of "Buy".

RELX Profile

RELX Plc engages in provision of information and analytics solutions for professional and business customers across industries. It operates through the following business segments: Scientific, Technical & Medical; Risk & Business Analytics; Legal; and Exhibitions. The Scientific, Technical & Medical segment is a global information analytics business that helps institutions and professionals advance healthcare, open science, and improve performance for the benefit of humanity.